The WVU Heart and Vascular Institute is the first in the state to offer the Barostim™ Baroreflex Activation Therapy, the world’s first FDA-approved heart failure device to use neuromodulation, to improve the symptoms of patients with systolic heart failure who may not receive adequate symptom relief from medications alone and those who are not suited for treatment with other heart failure devices, like cardiac resynchronization therapy.
Sign up to automatically receive new "In The News" articles daily.
In The NewsA subscription may be necessary to view the articles
Funding from the U.S. Department of Health and Human Services will go to Charleston Area Medical Center Health Education and Research Institute, Inc. to support telenursing software upgrades, telemedicine expansion, and cardiology services integration.
After a year of new spaces, new faces, and new miracles made, it’s time to celebrate at WVU Medicine Children’s Hospital.
For Josalyn Mann, D.O., one of the West Virginia School of Osteopathic Medicine’s eight regional assistant deans, one day of the year stands head and shoulders above all others.
Bonnie’s Bus mobile mammography unit will visit Lincoln, Kanawha, and Lewis counties offering three-dimensional (3D) digital screening mammograms and breast care education to women.
The holidays are a time for family, joy, and festivities—but can they also be a risk factor for a heart…
Obesity among adults is a major risk factor for cancer. In the United States, it’s been estimated that 14 percent of…
While some states allow for exemptions, West Virginia remains one of three to require child immunizations regardless of religious or…
Heart disease is the No. 1 killer of women, yet it doesn’t get the respect it deserves. Many women aren’t…